Abstract

BackgroundDepression and anxiety can be prevalent in newly diagnosed UA & RA patients and can be related to either environmental, social or for health reasons. The SERA study has enabled...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
OP0176 Five Year Outcomes of Remission Steered Treatment Including Drug Tapering Strategies in Early Arthritis Patients
C.F Allaart ... J.B Harbers
Annals of the Rheumatic Diseases | VOL. 75
C.F Allaart, et. al.C.F Allaart ... J.B Harbers
01 Jun 2016
THU0281 Do improvements in health-related quality of life during dmard treatment differ between psoriatic and rheumatoid arthritis patients? data from the prospective observational nor-dmard study, including baseline comparisons with norwegian general population controls
G Haugeberg ... T Uhlig
Annals of the Rheumatic Diseases | VOL. 77
G Haugeberg, et. al.G Haugeberg ... T Uhlig
01 Jun 2018
Follicular Helper T Cells in Peripheral Blood of Patients With Rheumatoid Arthritis
Eduardo Mussano ... Cristina Del Valle Acosta
Reumatología clínica (English Edition) | VOL. 13
Eduardo Mussano, et. al.Eduardo Mussano ... Cristina Del Valle Acosta
22 Sep 2017
Células T helper foliculares en sangre periférica de pacientes con artritis reumatoide
Paola Virginia Ferrero ... Laura Onetti
Reumatologia Clinica | VOL. 13
Paola Virginia Ferrero, et. al.Paola Virginia Ferrero ... Laura Onetti
29 Aug 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers